[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![wallstengine Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1508426880860704771.png) Wall St Engine [@wallstengine](/creator/twitter/wallstengine) on x 71.5K followers
Created: 2025-07-10 09:50:14 UTC

$KLTO GETS FDA ORPHAN DRUG STATUS FOR ALS GENE THERAPY

Klotho Neurosciences has secured FDA Orphan Drug Designation for its ALS gene therapy candidate KLTO-202. This gives KLTO tax credits, waived FDA fees, and X years of US market exclusivity. The therapy targets motor neuron damage by delivering secreted Klotho protein to blood, brain, and muscle. ALS affects fewer than XXXXXXX people in the US, with ~5,000 new cases each year.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943246376436933063/c:line.svg)

**Related Topics**
[tax bracket](/topic/tax-bracket)
[$klto](/topic/$klto)

[Post Link](https://x.com/wallstengine/status/1943246376436933063)